Leen Ann M.'s Form 4 filing
Kalaris Therapeutics, Inc. (KLRS) · filed Nov 16, 2021
- Accession no.
- 0000899243-21-044889
- Filed
- Nov 16, 2021
- Trade date
- Nov 12-16, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $465.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leen Ann M.CIK 0001763026 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2021 | Common Stock | SSaleDisposed | −14,266 | $22.26F2 | −$317,561.16 | 2,294,876 | Indirect | |
| Nov 12, 2021 | Common Stock | SSaleDisposed | −500 | $23.18F4 | −$11,590 | 2,294,376 | Indirect | |
| Nov 15, 2021 | Common Stock | SSaleDisposed | −6,122 | $21.92F5 | −$134,194.24 | 2,288,254 | Indirect | |
| Nov 16, 2021 | Common Stock | SSaleDisposed | −100 | $21.76 | −$2,176 | 2,288,154 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.81 to $22.66. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.99 to $23.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.75 to $22.35. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.